Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention - results from the clopidogrel for the reduction of events during observation (credo) trial

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Beinart, S. C.
  • Kolm, P.
  • Veledar, E.
  • Zhang, Z. F.
  • Mahoney, E. M.
  • Bouin, O.
  • Gabriel, S.
  • Jackson, J.
  • Chen, R.
  • Caro, J.
  • Steinhubl, Steven
  • Topol, Eric
  • Weintraub, W. S.

publication date

  • 2005

journal

  • Journal of the American College of Cardiology  Journal

subject areas

  • Aspirin
  • Cardiac Catheterization
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Stroke
  • Ticlopidine
  • Time Factors
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0735-1097

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2005.03.073

PubMed ID

  • 16139122
scroll to property group menus

Additional Document Info

start page

  • 761

end page

  • 769

volume

  • 46

issue

  • 5

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support